key: cord-0923944-idt3ndm6
authors: Adams, M.
title: Implications of red state/blue state differences in COVID-19 death rates
date: 2022-04-10
journal: nan
DOI: 10.1101/2022.04.08.22273628
sha: a9d8252e4d6afe74f5dd68753738401f79b3ddb1
doc_id: 923944
cord_uid: idt3ndm6

The study objective was to explore state death rates pre- and post- 4/19/2021 (date vaccines were assumed available) and the relative contributions of 3 factors to state death rates post- 4/19/2021: 1) vaccination rates, 2) prevalence of obesity, hypertension, diabetes, COPD, cardiovascular disease, and asthma and 3) red vs. blue states, to better understand options for reducing deaths. The ratio of red to blue state deaths/million was 1.6 pre-4/19/2021 and 2.3 between 4/19 and 2/28/2022 resulting in >222,000 extra deaths in red states or 305/ day. Adjusted betas from linear regression showed state vaccination rates had the strongest effect on death rates while red vs. blue states explained more of the difference in state death rates (60% vs. 46% for vaccination rates) with mean vaccination rates ~10% higher in blue states. Results suggest that increasing vaccination rates in red states could potentially save thousands of lives as the pandemic continues.

The cost of COVID-19 was estimated at $16 trillion (1) through the fall of 2021 and the death toll to 2/28/2022 was 943,775 and climbing, even with effective vaccines available (2). Obesity, hypertension, diabetes, COPD, cardiovascular disease, and asthma can affect death rates (3, 4) and higher death rates have been noted in red vs. blue states (5) . The study objective was first to explore state death rates pre-and post-4/19/2021 and second to use linear regression to explore the contributions of 3 factors to state death rates post-4/19/2021: 1) vaccination rates, 2) prevalence of the six chronic conditions and 3) red vs. blue states, to better understand opportunities for reducing deaths.

Methods COVID-19 deaths and the percentage of fully vaccinated adults on selected dates for each state were obtained from USA Facts (2). The date of 3/1/2020 was chosen as the beginning of the pandemic,4/19/2021 was chosen when vaccines were available, and adult vaccination rates were as of 8/27/2021. Publicly available 2019 Behavioral Risk Factor Surveillance System (BRFSS) data (6) from 409,810 adults from 49 states (no NJ) and DC, were used to obtain state prevalence rates for obesity, hypertension, diabetes, COPD, cardiovascular disease, and asthma (3, 4) . Data were weighted to be representative of the total adult population of each state. Median survey response rate was 49.4% (7) . States were coded as red (Trump) or blue (Clinton) based on voting in the 2016 election.

Number of deaths per day and mean deaths/million population pre-and post-4/19 were computed separately for red and blue states in Excel and compared. Stata version 14.2 was used for other analysis, using the survey option to account for the complex survey design of the . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 10, 2022. ; https://doi.org/10.1101/2022.04.08.22273628 doi: medRxiv preprint BRFSS unless otherwise noted. Regression models included the 3 factors together and each factor separately to estimate coefficients and R 2 . Regression was done with the survey option and repeated without the survey option to obtain standardized betas.

Total deaths (not per million) indicated that daily deaths decreased in blue states from 588/day pre-4/19/2021 to 373/day from 4/19-2/28/2022 while the number of daily deaths in red states increased from 769/day to 840/day in the same time periods. The change in blue states represents a 36% reduction in deaths/day and the change in red states represents a 9% increase resulting in >222,000 excess deaths in red states over 729 days or 305/day. Taking the different state populations into account, the ratio of red to blue state deaths/million was 1. Table 1 ; adults in red states had significantly higher prevalence rates for all measures listed except asthma and higher vaccination rates. Summary results for various regression models (Table 2) show vaccination rates, with standardized beta of 0.52, had the strongest effect on death rates while red vs. blue states explained more of the difference in state death rates (60% vs.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 10, 2022. ; https://doi.org/10.1101/2022.04.08.22273628 doi: medRxiv preprint 46% for vaccination rates). R 2 values for all models except just the COVID risks ranged from 0.46 for just vaccination rate to 0.62 for the model with all 3 factors and not requesting adjusted betas. Changes in selected dates did not substantially alter results.

Once vaccines were available, they had the strongest effect on death rates among the 3 factors, which is consistent with results that found vaccine effectiveness against death at 99% (98.5-99.6%) for fully vaccinated individuals (8) . As much as 62% of the difference between state COVID death rates was explained by the 3 factors combined, with 46% explained by just vaccination rates. Second in strength of effect on death rates was the variable representing red or blue states, which explained 60% of the difference in state death rates but represents a "black box" of factors. While these results don't identify all the differences between red and blue states, the measures in Table 1 offer some key differences: vaccination rates (which by themselves explained 46% of death rate differences), chronic conditions associated with higher COVID death rates, access to health care, general health status, disability, and receipt of a recent influenza vaccination were all worse in red states. Other possible factors affecting the death rates that likely differed between red and blue states include ways the pandemic was handled, including mask mandates, lockdowns, and other restrictions. Taken together, these differences resulted in a death rate/million in red states post 4/19/2021 that was 2.3 times that in blue states, an extra 222,000 deaths overall, and a 9% increase in death rates compared with the pre-vaccine period, at a time when the death rate in blue states decreased 36%.

There are several limitations to this study. Data on COVID deaths include deaths in nursing homes while the BRFSS data only include non-institutionalized adults. The impact of this . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 10, 2022. ; https://doi.org/10.1101/2022.04.08.22273628 doi: medRxiv preprint limitation can't be measured but is likely to be greater in the period prior to April 19 when the pandemic hit nursing homes hard. The data for vaccinations do not distinguish booster shots or any differences in the effectiveness of different brands. It is also difficult to determine (beyond the standardized beta results) which differences between red and blue states have the most influence on death rates or how those factors might be modified to lower death rates.

Perhaps putting these results in context with other studies might help. A study of 30 industrialized countries (9) found that obesity, population density, the age structure of the population, population health, GDP, ethnic diversity, and how the pandemic was handled explained 63% of the intercountry variation in COVID death rates. That regression R 2 was very similar to the R 2 of 0.60 for just red vs. blue states and the R 2 of 0.62 for the study model with all 3 factors but the global study excluded vaccination rates. Population density, age and racial composition, pandemic response, etc. are likely among the differences between red and blue states that contribute to that coefficient of determination of 0.60. From this list, only the handling of the pandemic seems amenable to modification, along with vaccination rates noted from this study. Given possible alternatives, increasing vaccination rates especially in red states seems the best option to reduce COVID deaths. Vaccine promotions may need to be carefully tailored to motivate this group. Success may be limited because differences will remain between red and blue states that can affect death rates, as they likely affected the differences in death rates seen before 4/19/2021.

Over the course of the pandemic through 2/28/2022, excess deaths in red states resulted in > 220,000 more deaths compared with blue states, or 305 deaths/day. Deaths are not the only cost of a pandemic (1), but this study did not compare dollar or other costs between red and blue . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 10, 2022. ; https://doi.org/10.1101/2022.04.08.22273628 doi: medRxiv preprint states. Other aspects of the pandemic such as the impact on healthcare systems and the economy may also be quite different for red and blue states.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 10, 2022. ; https://doi.org/10.1101/2022.04.08.22273628 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 10, 2022. ; https://doi.org/10.1101/2022.04.08.22273628 doi: medRxiv preprint

The COVID-19 Pandemic and the $16 Trillion Virus JAMA

USA Facts. US COVID-19 cases and deaths by state through date specified

Hospitalization rates and characteristics of patients hospitalized with laboratoryconfirmed coronavirus disease 2019-COVID-NET, 14 States

Updated Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease

ABC News 3/28/2022: Arielle Mitropoulos. For red and blue America, a glaring divide in COVID-19 death rates persists 2 years later

Centers for Disease Control and Prevention

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity

Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System

Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis

Obesity as a driver of international differences in COVID-19 death rates

International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity